OBSIDIAN SECURITY BCG MATRIX TEMPLATE RESEARCH B_116 high-margin cash to fund satellite

high-margin cash to fund satellite development

LimmaTech Biologics is developing a Klebsiella vaccine candidate in partnership with GSK

Partnerships with Citi and State Street offer financial backing and market credibility

Faster data processing

Intl Adjusted EBITDA $290M (+80% vs 2024)

OBSIDIAN SECURITY BCG MATRIX TEMPLATE RESEARCH B_116 high-margin cash to fund satelliteUnlock Strategic Clarity Obsidian Security's BCG Matrix preview highlights where its offerings sit amid rapid cyber market shifts identifying potential Stars in cloud native protection, Cash Cows in established detection, and Question Marks in emerging SaaS modules. This snapshot teases strategic priorities but skips the granular placement, market share curves, and margin overlays you need to act. Purchase the full BCG Matrix for quadrant by quadrant